Jose-Alberto Palma, MD, PhD is a physician-scientist with over fifteen years of experience in clinical trials and drug development, dedicated to advancing medical research and patient care. From 2015 to 2020, he worked as a principal investigator of neurodegeneration clinical trials at New York University (NYU) Grossman School of Medicine. In 2020, he transitioned to the pharmaceutical industry, taking on the global clinical trial lead role for neurodegeneration programs at Novartis, and continued this work at Eli Lily from 2023 onwards.